搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Encephalitozoon cuniculi RRM domain-containing protein ECU09_1470 (ECU09_1470) CSB-YP823402EKH
CSB-EP823402EKH
CSB-BP823402EKH
CSB-MP823402EKH
CSB-EP823402EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi UPF0328 protein ECU09_0020 (ECU09_0020) CSB-YP823403EKH
CSB-EP823403EKH
CSB-BP823403EKH
CSB-MP823403EKH
CSB-EP823403EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Probable glucose-repressible alcohol dehydrogenase transcriptional effector homolog (CCR4) CSB-YP823404EKH
CSB-EP823404EKH
CSB-BP823404EKH
CSB-MP823404EKH
CSB-EP823404EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Uncharacterized membrane protein ECU10_0880 (ECU10_0880), partial CSB-YP823405EKH1
CSB-EP823405EKH1
CSB-BP823405EKH1
CSB-MP823405EKH1
CSB-EP823405EKH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi UPF0328 protein ECU08_2080 (ECU08_2080) CSB-YP823406EKH
CSB-EP823406EKH
CSB-BP823406EKH
CSB-MP823406EKH
CSB-EP823406EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Uncharacterized protein ECU08_1280 (ECU08_1280) CSB-YP823407EKH
CSB-EP823407EKH
CSB-BP823407EKH
CSB-MP823407EKH
CSB-EP823407EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Uncharacterized protein ECU07_1090 (ECU07_1090) CSB-YP823408EKH
CSB-EP823408EKH
CSB-BP823408EKH
CSB-MP823408EKH
CSB-EP823408EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Uncharacterized Golgi apparatus protein ECU07_0400 (ECU07_0400) CSB-YP823409EKH
CSB-EP823409EKH
CSB-BP823409EKH
CSB-MP823409EKH
CSB-EP823409EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi UPF0328 protein ECU06_1650 (ECU06_1650) CSB-YP823410EKH
CSB-EP823410EKH
CSB-BP823410EKH
CSB-MP823410EKH
CSB-EP823410EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Homeobox protein HD-3 (HD-3) CSB-YP823411EKH
CSB-EP823411EKH
CSB-BP823411EKH
CSB-MP823411EKH
CSB-EP823411EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi UPF0329 protein ECU06_0050 (ECU06_0050) CSB-YP823412EKH
CSB-EP823412EKH
CSB-BP823412EKH
CSB-MP823412EKH
CSB-EP823412EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Uncharacterized protein ECU05_0590 (ECU05_0590) CSB-YP823413EKH
CSB-EP823413EKH
CSB-BP823413EKH
CSB-MP823413EKH
CSB-EP823413EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi UPF0329 protein ECU04_1670 (ECU04_1670), partial CSB-YP823414EKH
CSB-EP823414EKH
CSB-BP823414EKH
CSB-MP823414EKH
CSB-EP823414EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Uncharacterized membrane protein ECU04_1080 (ECU04_1080), partial CSB-YP823415EKH1
CSB-EP823415EKH1
CSB-BP823415EKH1
CSB-MP823415EKH1
CSB-EP823415EKH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Homeobox protein HD-10 (HD-10) CSB-YP823416EKH
CSB-EP823416EKH
CSB-BP823416EKH
CSB-MP823416EKH
CSB-EP823416EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Homeobox protein HD-7 (HD-7) CSB-YP823417EKH
CSB-EP823417EKH
CSB-BP823417EKH
CSB-MP823417EKH
CSB-EP823417EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi UPF0328 protein ECU03_0080 (ECU03_0080) CSB-YP823418EKH
CSB-EP823418EKH
CSB-BP823418EKH
CSB-MP823418EKH
CSB-EP823418EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Ubiquitin (ECU02_0740i) CSB-YP823419EKH
CSB-EP823419EKH
CSB-BP823419EKH
CSB-MP823419EKH
CSB-EP823419EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Heat shock protein ECU02_0100 (ECU02_0100), partial CSB-YP823420EKH
CSB-EP823420EKH
CSB-BP823420EKH
CSB-MP823420EKH
CSB-EP823420EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Encephalitozoon cuniculi Probable cell cycle serine/threonine-protein kinase CDC5 homolog (CDC5) CSB-YP823421EKH
CSB-EP823421EKH
CSB-BP823421EKH
CSB-MP823421EKH
CSB-EP823421EKH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>